| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Tenaya Therapeutics, Inc.
13D/A
TNYA · 87990A106
|
23.1% |
2/26/2026
Event 2/25/2026
|
||||
| The Column Group III, LP | 0% | |||||
| The Column Group III-A, LP | 0% | |||||
| The Column Group III GP, LP | 0% | |||||
| The Column Group Opportunity III, LP | 23.1% | |||||
| The Column Group Opportunity III GP, LP | 23.1% | |||||
| TCG Opportunity III GP, LLC | 23.1% | |||||
| Tim Kutzkey | 23.1% | |||||
| Peter Svennilson | 23.1% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.